Cargando…
Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease
As the world's population ages, the incidence of Parkinson's disease (PD), the second most common neurological ailment, keeps increasing. It is estimated that 1% of the global population over the age of 60 has the disease. The continuous loss of dopaminergic neurons and the concomitant bra...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724695/ https://www.ncbi.nlm.nih.gov/pubmed/36540116 http://dx.doi.org/10.1039/d2na00524g |